Healthpeak Properties, Inc. (NYSE:DOC) Given Average Rating of "Moderate Buy" by Brokerages

Key Points

• Healthpeak Properties, Inc. has received an average rating of "Moderate Buy" from 13 analysts, with 8 recommending a buy and 5 suggesting a hold.
• The current average twelve-month price objective for Healthpeak Properties is $21.33, with recent analyst ratings ranging from $19.00 to $22.00.
• Insider trading activity has been noted, including a recent purchase of 2,930 shares by CEO Scott M. Brinker, increasing his ownership stake in the company.

Healthpeak Properties, Inc. (NYSE:DOC - Get Free Report) has earned an average rating of "Moderate Buy" from the thirteen analysts that are currently covering the firm, MarketBeat reports. Five investment analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $21.3333.

A number of equities research analysts have recently commented on the company. Scotiabank lowered Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and dropped their price target for the stock from $21.00 to $19.00 in a research report on Tuesday, July 29th. Raymond James Financial upgraded Healthpeak Properties from a "market perform" rating to an "outperform" rating and set a $20.00 price objective for the company in a report on Monday, September 15th. Evercore ISI set a $22.00 price objective on Healthpeak Properties in a report on Monday, September 15th. Robert W. Baird set a $21.00 price objective on Healthpeak Properties and gave the stock an "outperform" rating in a report on Wednesday, July 30th. Finally, Morgan Stanley decreased their price objective on Healthpeak Properties from $22.00 to $21.00 and set an "overweight" rating for the company in a report on Friday, August 22nd.

Insiders Place Their Bets

In related news, CEO Scott M. Brinker purchased 2,930 shares of the firm's stock in a transaction on Thursday, July 31st. The stock was purchased at an average cost of $17.06 per share, for a total transaction of $49,985.80. Following the completion of the purchase, the chief executive officer directly owned 210,416 shares in the company, valued at $3,589,696.96. This trade represents a 1.41% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders purchased 8,783 shares of company stock valued at $150,129 in the last ninety days. 0.23% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. Machina Capital S.A.S. boosted its stake in shares of Healthpeak Properties by 62.8% during the 1st quarter. Machina Capital S.A.S. now owns 37,160 shares of the real estate investment trust's stock worth $751,000 after acquiring an additional 14,336 shares during the period. Cambridge Investment Research Advisors Inc. boosted its stake in shares of Healthpeak Properties by 6.9% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 357,520 shares of the real estate investment trust's stock worth $7,229,000 after acquiring an additional 23,135 shares during the period. Deutsche Bank AG boosted its stake in shares of Healthpeak Properties by 0.3% during the 1st quarter. Deutsche Bank AG now owns 8,482,898 shares of the real estate investment trust's stock worth $171,524,000 after acquiring an additional 23,136 shares during the period. Concurrent Investment Advisors LLC boosted its stake in shares of Healthpeak Properties by 10.9% during the 1st quarter. Concurrent Investment Advisors LLC now owns 11,218 shares of the real estate investment trust's stock worth $227,000 after acquiring an additional 1,101 shares during the period. Finally, Oppenheimer Asset Management Inc. boosted its stake in shares of Healthpeak Properties by 58.8% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 1,015,174 shares of the real estate investment trust's stock worth $20,527,000 after acquiring an additional 375,747 shares during the period. 93.57% of the stock is currently owned by institutional investors.

Healthpeak Properties Trading Up 1.1%

NYSE DOC opened at $18.16 on Wednesday. The firm has a market cap of $12.62 billion, a P/E ratio of 75.69, a P/E/G ratio of 3.06 and a beta of 1.09. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.28 and a quick ratio of 1.28. The stock's 50-day moving average is $18.07 and its 200-day moving average is $17.93. Healthpeak Properties has a one year low of $16.63 and a one year high of $23.26.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting analysts' consensus estimates of $0.46. The company had revenue of $694.35 million for the quarter, compared to analyst estimates of $697.14 million. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%.Healthpeak Properties's revenue was down .2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.45 earnings per share. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. Sell-side analysts anticipate that Healthpeak Properties will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The company also recently disclosed a monthly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 19th will be issued a dividend of $0.1017 per share. The ex-dividend date is Friday, December 19th. This represents a c) dividend on an annualized basis and a dividend yield of 6.7%. Healthpeak Properties's dividend payout ratio (DPR) is presently 508.33%.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.